Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs
ConclusionM2BPGi at SVR is a potential predictor for patients ’ survival and a candidate biomarker for detecting individuals who are at greater risk of death due to cancer-related and unrelated to HCV, as well as cardiovascular diseases, after viral eradication.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Databases & Libraries | Gastroenterology | Heart | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Smokers | Statistics | Study | Urology & Nephrology | Virology